Fosaprepitant dimeglumine Manufacturers

Markets of interest

As an antiemetic drug, Fosaprepitant dimeglumine is prescribed to treat such side effects of chemotherapy treatment as nausea and vomiting. The medication works by interfering with the neurotransmitter receptors involved in vomiting. The drug is used together with other medications to prevent nausea and vomiting that may be caused by chemotherapy in adults and children who are at least 6 months old. This medication is given ahead of time and will not treat nausea or vomiting that you already have. The drug is available for sale in the form of vials, a solution for injection at a concentration of 150 ml per unit, from manufacturers in various countries including Y. The drug is provided by a wide range of Fosaprepitant dimeglumine suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Fosaprepitant dimeglumine manufacturers and distributors are based in India and China.

Licensing and brand names

Fosaprepitant dimeglumine was approved by the FDA in the USA in 2008. The same year the medication was approved by the EMA in the European Union. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Emend, Emend IV, and Ivemend. One of the most popular branded versions of Fosaprepitant dimeglumine is manufactured and supplied by the Indian pharmaceutical company MSN Labs. Other manufacturing companies and distributors from the USA and Taiwan have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Fosaprepitant dimeglumine as an active ingredient.

Target supply price

The wholesale acquisition cost of medication in the USA for Fosaprepitant dimeglumine intravenous powder for injection 150 mg is around $64 for a supply of 1 powder for injection. The retail price of the Fosaprepitant dimeglumine capsules, depending on the substance concentration in one unit, reaches 61 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Fosaprepitant dimeglumine manufacturers and suppliers that you are looking for. You can also find the dossier status of Fosaprepitant dimeglumine and the GMP approvals of the different variants of the medication. The product description of all Fosaprepitant dimeglumine suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Fosaprepitant dimeglumine is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.